In an accompanying editorial, Christopher K. Varley, M.D., and Jon McClellan, M.D., of Seattle Children's Hospital, said that while "these medications can be lifesaving for youth with serious psychiatric illnesses such as schizophrenia, classically defined bipolar disorder, or severe aggression associated with autism," and "given the risk for weight gain and long-term risk for cardiovascular and metabolic problems, the widespread and increasing use of atypical antipsychotic medications in children and adolescents should be reconsidered."
About The Feinstein Institute for Medical Research
Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in cancer, leukemia, lymphoma, Parkinson's disease, Alzheimer's disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, inflammatory bowel disease, diabetes, human genetics, neuroimmunology, and medicinal chemistry. Feinstein researchers are developing new drugs and drug targets, and producing results where science meets the patient, annually enrolling some 10,000 subjects into clinical research programs.
About The Zucker Hillside Hospital
The Zucker Hillside Hospital is home to many of the nation's experts on severe mental illness. In addition to treating patients in and out of the hospital, psychiatric research has been ongoing for decades and includes landmark studies on the treatment and course of first-episode psychotic patients. Genetics also plays a critical role in severe mental illness and scientists at the Zucker Hillside Hospital have identified several important risk ge
'/>"/>
| Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved |